GLP-1RA Liraglutide and Semaglutide Improves Obesity-Induced Muscle Atrophy via SIRT1 Pathway

Jie Xiang, Liyan Qin, Jinling Zhong, Xia Ning, Yuzhen Liang

Diabetes Metabolic Syndrome and Obesity · 2023 · 75 citations · 37 references

DOIFull text

Open access

Abstract

Liraglutide and semaglutide protects skeletal muscle against obesity-induced muscle atrophy via the SIRT1 pathway.

References

37